-
U.S. lawmakers want tighter food inspection system
The list of recalled peanut products in the .S. surpassed 1,000 in an ongoing national salmonella outbreak; the 2007 recall of melamine-tainted pet food eventually grew to 1,179 products; Congress says current system of food inspection is not working
-
-
40 al-Qaeda terrorists dead after failed experiment with plague weapon
40 al-Qaeda members died after being exposed to the plague during a biological weapons test; test took place in cave hideouts in Tizi Ouzou province, 150 kilometres east of the Algerian capital Algiers
-
-
Kansas wins $450 million biolab
Kansas State University outlasted four other competitors to win the $450 million DHS National Bio- and Agro-Defense Facility
-
-
India's bioterror plans will take some time to get off the ground
India is augmenting its preparations for bioterror attacks; experts complain that one of the major weaknesses in India’s ability to cope with a bioterror attack is the lack of interest, so far, of the private sector in being enlisted in the effort
-
-
Graham, Talent: U.S. should do more to prevent terrorist attack
The leaders of the Commission on the Prevention of WMD Proliferation and Terrorism say that the incoming administration must do more, much more, to prevent a terrorist attack on the United States
-
-
The continuing development of Fort Detrick offers business opportunities
In some places there is a debate about the balance between the business opportunities and risks that the presence of a BioLab facility offers; in Washington County, Maryland, they concentrate on the business opportunities the sprawling — and growing — Fort Detrick (it covers 1,127 acres and employs more than 8,000 people) offers
-
-
Economic downturn to hurt medical emergency preparedness
Progress made better to protect the United States from disease outbreaks, natural disasters, and bioterrorism is now at risk, due to budget cuts and the economic crisis
-
-
Independent commission: WMD attack by terrorists likely
An independent commission of experts, set up by Congress as part of the recommendations by the 9/11 commission, concludes that terrorists will most likely carry out an attack with biological, nuclear, or other unconventional weapons somewhere in the world in the next five years
-
-
New anti-viral shows promise against bioterror agent
University of Texas researchers successfully tests new anti-viral drug against Lassa fever — an endemic disease in portions of West Africa; CDC lists Lassa fever as a Category A bioterrorism agent
-
-
Briefly noted
ESTA Authorization required for all visa waiver countries as of 12 January… Georgia vet school leak kept quiet… Microsoft infuses “long awaited” with new meaning
-
-
Anti-bioterror programs may make U.S. more vulnerable
There are 14 BSL-4 labs in the United States (6 already in operation; 3 completed but not yet operational; 5 under construction), and 15,000 scientists authorized to work with deadly pathogens; critics argue that by vastly increasing the number of researchers and labs authorized to handle deadly substances, the government has made the U.S. more vulnerable to bioterror attacks
-
-
Biosafety Lab-Level 4 dedicated in Galveston, Texas
The $174 million, 186,267-square-foot lab will employ 300 people; the lab is one of two approved in 2003 by NIH (the second is being built in Boston); critics question placing a BSL-4 lab on a barrier island vulnerable to hurricanes
-
-
The ethics of treatment during pandemic
It is more or less agreed that during the outbreak of a pandemic or a bioterror attack, those deemed “essential” to the functioning of the society should receive treatment first; but how do we define “essential”?
-
-
New technique to detect individual molecules
Even very small numbers of deadly infectious agents or allergenic pollen molecules can cause major problems for humans — but detecting such trace amounts has been difficult to accomplish with enough speed to do any good; new detection technique solves the problem
-
-
HHS offers legal shield to anthrax manufacturers, distributors
The U.S. Department of Health and Human Services offers legal shield to manufacturers and distributors of anthrax vaccines and treatments under a “public health emergency” to be in effect until the end of 2015
-
